Published in Pediatr Nephrol on April 01, 1994
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Tacrolimus in pediatric renal transplantation. Transplantation (1996) 1.18
FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol (1995) 1.11
Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation (1999) 1.00
Improving results of pediatric renal transplantation. J Am Coll Surg (1994) 0.82
Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol (2015) 0.82
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation (2007) 0.78
Tacrolimus-based immunosuppression in pediatric renal transplantation. Transplant Proc (1999) 0.75
Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting. Pediatr Neurol (2002) 0.75
Cyclosporin A stimulates apical Na+/H+ exchange in LLC-PK1/PKE20 proximal tubular cells. Pediatr Nephrol (2006) 0.75
Lip hypertrophy secondary to cyclosporin treatment. Pediatr Nephrol (2003) 0.75
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Kidney transplantation under FK 506. JAMA (1990) 7.45
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11
Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00
Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
Medical education and health for all. Aust J Public Health (1995) 2.65
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol (2013) 2.51
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
Immunodepression after major surgery in normal patients. Surgery (1975) 2.48
Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27
On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24
Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20
Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11
Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06
Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01
Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00
Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet (1990) 1.94
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90
The point system for organ distribution. Transplant Proc (1989) 1.88
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Pancreatic trauma: a review. Surgery (1972) 1.81
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Family tension in the search for a kidney donor. JAMA (1971) 1.77
Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77
Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution. EMBO J (1997) 1.77
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76
Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74
Specific acylation of the guanine residues of ribonucleic acid. J Biol Chem (1970) 1.74
Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71
Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use. Pediatrics (1993) 1.71
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69
Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation (1989) 1.67
Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Cryoablation of unresectable malignant liver tumors. Am J Surg (1996) 1.62
Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59
The spectrum of portal vein thrombosis in liver transplantation. Ann Surg (1991) 1.58
Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol (1992) 1.58
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Nurses' attitudes toward death and caring for dying patients. Oncol Nurs Forum (1999) 1.58
Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry (1989) 1.57
Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem (1980) 1.56
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol (2000) 1.56
Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases. Pediatr Nephrol (1999) 1.55
Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci U S A (1987) 1.55
Acidic hydrolysis of deoxycytidine and deoxyuridine derivatives. The general mechanism of deoxyribonucleoside hydrolysis. Biochemistry (1972) 1.54
Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54
Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood (1989) 1.53